Comparing current US and European guidelines for nosocomial pneumonia

被引:12
作者
Kelly, Daire N. [1 ]
Martin-Loeches, Ignacio [1 ,2 ,3 ]
机构
[1] St James Hosp, MICRO, Dept Intens Care Med, Jamess St N, Dublin D03 VX82, Ireland
[2] Hosp Clin Barcelona, IDIBAPS, CIBER, Pulm Intens Care Unit,Resp Inst, Barcelona, Spain
[3] Univ Barcelona, Dept Med, Barcelona, Spain
关键词
hospital-acquired pneumonia; ICU; pneumonia; sepsis; ventilator-associated pneumonia; VENTILATOR-ASSOCIATED PNEUMONIA; BETA-LACTAM INFUSION; INTENSIVE-CARE-UNIT; OROPHARYNGEAL DECONTAMINATION; ANTIBIOTIC-THERAPY; PHARMACOKINETICS; CHLORHEXIDINE; PREVENTION; MANAGEMENT; RESISTANCE;
D O I
10.1097/MCP.0000000000000559
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose of review In the last 2 years, two major guidelines for the management of nosocomial pneumonia have been published: The International European Respiratory Society/European Society of Intensive Care Medicine/European Society of Clinical Microbiology and Infectious Diseases/Asociacion Latinoamericana de Torax guidelines for the management of hospital- acquired pneumonia (HAP) and ventilator- associated pneumonia (VAP) and the American guidelines for management of adults with HAP and VAP; both the guidelines made important clinical recommendations for the management of patients. Recent findings With the increasing emergence of multidrug resistant (MDR) organisms, paired with a relative reduction in new antibiotic development, nosocomial infections have become one of the most significant issues affecting global healthcare today. Despite several stark differences between the European and American guidelines, they are in agreement about many aspects of nosocomial pneumonia management. Summary American and European guidelines promote prompt and appropriate empiric treatment which is immediately guided by local microbiological data, followed by an adequate de- escalation protocol based on culture results with a 1- week course of treatment. Both also questioned the use of biomarkers in HAP/VAP, whether as part of the diagnosis or daily assessment of patients. On the contrary, they have conflicting views in regards to the optimum method of diagnosis, the risk factors used to stratify patients, the use of clinical scoring systems and the various antibiotic classes used. All were presented with varying levels of evidence to support these differences in opinion, indicating that further research into these areas is required before a consensus can be agreed upon.
引用
收藏
页码:263 / 270
页数:8
相关论文
共 50 条
  • [1] Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
    Abdul-Aziz, Mohd H.
    Sulaiman, Helmi
    Mat-Nor, Mohd-Basri
    Rai, Vineya
    Wong, Kang K.
    Hasan, Mohd S.
    Abd Rahman, Azrin N.
    Jamal, Janattul A.
    Wallis, Steven C.
    Lipman, Jeffrey
    Staatz, Christine E.
    Roberts, Jason A.
    [J]. INTENSIVE CARE MEDICINE, 2016, 42 (10) : 1535 - 1545
  • [3] [Anonymous], EUR RESP J
  • [4] [Anonymous], COMP EFFECTIVENESS R
  • [5] [Anonymous], J INTENSIVE CARE MED
  • [6] [Anonymous], CRIT CARE MED
  • [7] The Impact of Antimicrobial Resistance and Aging in VAP Outcomes: Experience from a Large Tertiary Care Center
    Arvanitis, Marios
    Anagnostou, Theodora
    Kourkoumpetis, Themistoklis K.
    Ziakas, Panayiotis D.
    Desalermos, Athanasios
    Mylonakis, Eleftherios
    [J]. PLOS ONE, 2014, 9 (02):
  • [8] Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia
    Berton, Danilo Cortozi
    Kalil, Andre C.
    Zimermann Teixeira, Paulo Jose
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [9] Selective decontamination of the digestive tract halves the prevalence of ventilator-associated pneumonia compared to selective oral decontamination
    Bos, Lieuwe D.
    Stips, Cheryl
    Schouten, Laura R.
    van Vught, Lonneke A.
    Wiewel, Maryse A.
    Wieske, Luuk
    van Hooijdonk, Roosmarijn T.
    Straat, Marleen
    de Beer, Friso M.
    Glas, Gerie J.
    Visser, Caroline E.
    de Jonge, Evert
    Juffermans, Nicole P.
    Horn, Janneke
    Schultz, Marcus J.
    [J]. INTENSIVE CARE MEDICINE, 2017, 43 (10) : 1535 - 1537
  • [10] Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study
    Braunero, Stephan
    Koenig, Christina
    Roberts, Jason A.
    Nierhaus, Axel
    Steinmetz, Oliver
    Baehr, Michael
    Kluge, Stefan
    Langebrake, Claudia
    [J]. CRITICAL CARE, 2018, 22